Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Welcome to the Laboratory of Doctor Pibarot's Team
Our Mission
To develop innovatives approaches to improve the diagnosis, prevention, and treatment of valvular heart diseases. We aim to determine the mechanisms underlying the development and progression of valvular heart diseases.
What are Valvular Heart Diseases ?
Heart valve diseases are characterized by one or more failing heart valves, typically due to improper opening or closing, which disrupts normal blood flow.
Who Are We ?
A research team located at the Research Center of the Quebec Heart and Lung Institute affiliated with Laval University (CRIUCPQ-ULaval). Led by Dr. Philippe Pibarot, an international expert in valvular diseases, our team has made significant advancements in the diagnosis and treatment of heart valve diseases
Did you know ?
Aortic stenosis is the most common heart valve disease in high income countries. Currently, there is no medical treatment able to slow or halt the progression of this frequent and serious condition.
Surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) are the only solutions available today to treat aortic stenosis.
Similarly, mitral regurgitation, also known as mitral insufficiency, is one of the most common valve diseases among adults and is associated with high rates of morbidity and mortality. As with aortic stenosis, there is no medical treatment able to slow or halt its progression. The only therapeutic options are mitral valve surgery or percutaneous intervention.
Reach Us
Address :
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval
2725 Chemin Sainte-Foy, Québec, (QC) G1V 4G5, CANADA
Email adresses
Director : philippe.pibarot@med.ulaval.ca
Co-director : nancy.cote@criucpq.ulaval.ca